Stimcell Energetics (STME) Change in Cash (2011 - 2026)
Stimcell Energetics' (STME) quarterly Change in Cash came in at -$35902.0 in Q1 2026, down 32.27% year-on-year from -$53007.4 in Q1 2025, and down 190.38% quarter-over-quarter from $39722.0 in Q4 2025.
Stimcell Energetics (STME) Change in Cash (2011 - 2026) Analysis & Trends
Stimcell Energetics' Change in Cash history runs 14 years deep, the most recent figure standing at -$35902.0 for Q1 2026.
- On a quarterly basis, Change in Cash fell 32.27% year-over-year to -$35902.0 in Q1 2026; TTM through Feb 2026 was $3579.0, a 104.9% increase from a year earlier, with the FY2025 full-year figure at -$28834.0, up 47.46% from the prior year.
- Change in Cash declined to -$35902.0 in Q1 2026 per STME's latest filing, from $39722.0 in the prior quarter.
- Across five years, Change in Cash topped out at $90667.0 in Q2 2023 and bottomed at -$40221.0 in Q3 2023.
- The 5-year median for Change in Cash is -$8144.0 (2025), against an average of -$1581.8.
- Biggest YoY gain for Change in Cash was 1526.48% in 2023; the steepest drop was 532.7% in 2023.
- Year by year, Change in Cash stood at $8193.0 in 2022, then slumped by 532.7% to -$35451.0 in 2023, then jumped by 137.43% to $13269.0 in 2024, then soared by 199.36% to $39722.0 in 2025, then sank by 190.38% to -$35902.0 in 2026.
- Per Business Quant, the three latest STME Change in Cash figures stand at -$35902.0 (Q1 2026), $39722.0 (Q4 2025), and -$8144.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.72 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.13 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -504.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -492.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | -35,902.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -35,902.00 |
| Nov 30, 2025 | 39,722.00 |
| Aug 31, 2025 | -8,144.00 |
| May 31, 2025 | 7,903.00 |
| Feb 28, 2025 | -27,143.00 |
| Nov 30, 2024 | 13,269.00 |
| Aug 31, 2024 | -22,863.00 |
| May 31, 2024 | -36,262.00 |
| Feb 29, 2024 | 57,054.00 |
| Nov 30, 2023 | -35,451.00 |
| Aug 31, 2023 | -40,221.00 |
| May 31, 2023 | 90,667.00 |
| Feb 28, 2023 | -10,185.00 |
| Nov 30, 2022 | 8,193.00 |
| Aug 31, 2022 | -14,760.00 |
| May 31, 2022 | -6,356.00 |
| Feb 28, 2022 | -6,411.00 |
| Nov 30, 2021 | -26,625.00 |
| Aug 31, 2021 | 43,019.00 |
| May 31, 2021 | -5,214.00 |